{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:39:04Z","timestamp":1774953544032,"version":"3.50.1"},"reference-count":54,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2017,1,3]]},"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Despite a large volume of evidence supporting the use of dual antiplatelet therapy in patients with acute coronary syndrome, there remains major uncertainty regarding the optimal duration of therapy. Clinical trials have varied markedly in the duration of therapy, both across and within trials. Recent systematic reviews and meta-analyses suggest that shorter durations of dual antiplatelet therapy are superior because the avoidance of atherothrombotic events is counterbalanced by the greater risks of excess major bleeding with apparent increases in all-cause mortality with longer durations. These findings did not show significant heterogeneity according to whether patients had stable or unstable coronary heart disease. Moreover, the potential hazards and benefits may differ when applied to the general broad population of patients encountered in everyday clinical practice who have markedly higher bleeding and atherothrombotic event rates. Clinicians lack definitive information regarding the duration of therapy in patients with acute coronary syndrome and risk scores do not appear to be sufficiently robust to address these concerns. We believe that there is a pressing need to undertake a broad inclusive safety trial of shorter durations of therapy in real world populations of patients with acute coronary syndrome. The clinical evidence would further inform future research into strategies for personalised medicine.<\/jats:p>","DOI":"10.1136\/heartjnl-2016-309871","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T20:20:23Z","timestamp":1488399623000},"page":"573-580","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":36,"title":["Duration of dual antiplatelet therapy in acute coronary syndrome"],"prefix":"10.1136","volume":"103","author":[{"given":"Simon John","family":"Wilson","sequence":"first","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, New Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Newby","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, New Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Dawson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Irving","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ninewells Hospital, Dundee, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"2025101709562870000_103.8.573.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"2025101709562870000_103.8.573.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060989"},{"key":"2025101709562870000_103.8.573.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002358"},{"key":"2025101709562870000_103.8.573.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"2025101709562870000_103.8.573.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"2025101709562870000_103.8.573.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198511283132201"},{"key":"2025101709562870000_103.8.573.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308183090703"},{"key":"2025101709562870000_103.8.573.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67660-X"},{"key":"2025101709562870000_103.8.573.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050522"},{"key":"2025101709562870000_103.8.573.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500857"},{"key":"2025101709562870000_103.8.573.11","first-page":"2949","article-title":"ESC guidelines on the management of stable coronary artery disease","volume":"2013","author":"Members","year":"2013","journal-title":"Eur Heart J"},{"key":"2025101709562870000_103.8.573.12","first-page":"e123","article-title":"ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-Elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with Non\u2013ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery","volume":"2016","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"2025101709562870000_103.8.573.13","first-page":"267","article-title":"ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"2016","author":"Roffi","year":"2015","journal-title":"Eur Heart J"},{"key":"2025101709562870000_103.8.573.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.10.026"},{"key":"2025101709562870000_103.8.573.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.2.joc60179"},{"key":"2025101709562870000_103.8.573.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.022"},{"key":"2025101709562870000_103.8.573.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.06.043"},{"key":"2025101709562870000_103.8.573.18","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"2025101709562870000_103.8.573.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.11.008"},{"key":"2025101709562870000_103.8.573.20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu523"},{"key":"2025101709562870000_103.8.573.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.008"},{"key":"2025101709562870000_103.8.573.22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.059022"},{"key":"2025101709562870000_103.8.573.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.071589"},{"key":"2025101709562870000_103.8.573.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq326"},{"key":"2025101709562870000_103.8.573.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003303"},{"key":"2025101709562870000_103.8.573.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60612-7"},{"key":"2025101709562870000_103.8.573.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409312"},{"key":"2025101709562870000_103.8.573.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1618"},{"key":"2025101709562870000_103.8.573.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.512"},{"key":"2025101709562870000_103.8.573.30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv443"},{"key":"2025101709562870000_103.8.573.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001803"},{"key":"2025101709562870000_103.8.573.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.03.010"},{"key":"2025101709562870000_103.8.573.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055443"},{"key":"2025101709562870000_103.8.573.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708191"},{"key":"2025101709562870000_103.8.573.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.060"},{"key":"2025101709562870000_103.8.573.36","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn358"},{"key":"2025101709562870000_103.8.573.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.04.010"},{"key":"2025101709562870000_103.8.573.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60292-6"},{"key":"2025101709562870000_103.8.573.39","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr204"},{"key":"2025101709562870000_103.8.573.40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.23.2908"},{"key":"2025101709562870000_103.8.573.41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.1.71"},{"key":"2025101709562870000_103.8.573.42","doi-asserted-by":"publisher","DOI":"10.1159\/000022446"},{"key":"2025101709562870000_103.8.573.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005313222201"},{"key":"2025101709562870000_103.8.573.44","doi-asserted-by":"crossref","unstructured":"Hamid T , Zaman M . Switching of ticagrelor to Clopidogrel at 3 months in patients treated for acute care syndrome; Single centre experience. Cardiovasc Pharm: Open Access 2016;5.doi:10.4172\/2329-6607.1000194","DOI":"10.4172\/2329-6607.1000194"},{"key":"2025101709562870000_103.8.573.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.09.012"},{"key":"2025101709562870000_103.8.573.46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3775"},{"key":"2025101709562870000_103.8.573.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.02.064"},{"key":"2025101709562870000_103.8.573.48","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.181"},{"key":"2025101709562870000_103.8.573.49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.17312"},{"key":"2025101709562870000_103.8.573.50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.290"},{"key":"2025101709562870000_103.8.573.51","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92336-G"},{"key":"2025101709562870000_103.8.573.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308183090703"},{"key":"2025101709562870000_103.8.573.53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198511283132201"},{"key":"2025101709562870000_103.8.573.54","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00331-J"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2016-309871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:56:38Z","timestamp":1760720198000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2016-309871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,3,28]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1136\/heartjnl-2016-309871"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2016-309871","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]}}}